Insider Insights
13.07.2022
Big pharmas lose out in Chinas latest round of dru

AZ has warned its China revenues will decline mid-single-digit percentage in 2022 after years of dou...

Read more
Insider Insights
13.07.2022
NICE expands access of Tremfya in England and Wale

The HTA initially recommended Tremfya as a treatment option for adults with active psoriatic arthrit...

Read more
Insider Insights
11.07.2022
New pharmaceutical updated cost containment measur

This updated bill contains some similar measures to those proposed in March as well as some addition...

Read more
Insider Insights
27.06.2022
Health innovation plan

France’s Health Innovation Plan 2030, announced by President Emmanuel Macron back in June 2021, wi...

Read more
Insider Insights
27.06.2022
EURORDIS release joint statement on patient access

They came up with six proposals, split into three subgroups, aimed at addressing the key barriers to...

Read more
Insider Insights
23.06.2022
NICE publish their new real world evidence framewo

NICE have been clear that this framework should not be interpreted as minimum standards for real-wor...

Read more
Insider Insights
23.06.2022
AIFA reorganisation delayed again

It is widely expected that the reform will entail the unification of the CTS and the CPR into one bo...

Read more
Insider Insights
21.06.2022
Sweden TLV considers cost containment measures

According to the TLV, “The prices of medicines that have been on the market between 5 and 15 years...

Read more
Insider Insights
20.06.2022
NICE trials new proportionate approach to increase

The aim of this trial is to increase capacity, with a goal of a 20% increase by 2023-24.

Read more
Insider Insights
15.06.2022
NHS announces further details of subscription styl

The subscription-style payment model for antibiotics announced by NICE in April 2022 will be capped ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.